Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)

SHA:688621 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,240	4,222	7,812	8,192	9,728	-
Market Cap Growth	-28.66%	-45.95%	-4.64%	-15.79%	-	-
Enterprise Value	6,188	4,027	7,561	7,889	9,536	-
Last Close Price	57.10	37.70	69.47	72.35	85.66	-
PE Ratio	47.69	23.80	42.28	52.35	92.07	-
Forward PE	-	31.74	31.74	41.58	79.34	-
PS Ratio	5.90	3.92	8.38	12.11	19.71	-
PB Ratio	6.06	3.83	7.39	9.02	12.64	-
P/TBV Ratio	6.24	3.95	7.75	9.45	13.28	-
P/FCF Ratio	318.00	2749.41	392.53	89126.79	2953.42	-
P/OCF Ratio	172.61	131.87	84.13	78.80	110.23	-
EV/Sales Ratio	5.85	3.73	8.11	11.66	19.32	-
EV/EBITDA Ratio	35.49	19.96	35.09	45.56	72.53	-
EV/EBIT Ratio	49.43	22.84	39.08	50.53	79.49	-
EV/FCF Ratio	315.38	2621.91	379.91	85835.42	2895.08	-
Debt / Equity Ratio	0.60	0.41	0.42	0.28	0.27	0.12
Debt / EBITDA Ratio	3.55	2.03	1.88	1.32	1.40	0.26
Debt / FCF Ratio	31.56	296.79	22.44	2802.12	62.76	0.65
Asset Turnover	0.51	0.56	0.56	0.50	0.61	1.04
Inventory Turnover	35.30	36.48	29.97	29.56	32.55	34.90
Quick Ratio	1.49	1.80	1.69	1.93	2.15	1.17
Current Ratio	1.64	1.95	1.78	2.01	2.25	1.37
Return on Equity (ROE)	12.54%	15.65%	18.61%	18.91%	22.61%	47.59%
Return on Assets (ROA)	3.80%	5.72%	7.27%	7.21%	9.21%	15.32%
Return on Capital (ROIC)	4.81%	7.20%	9.06%	9.11%	12.57%	29.59%
Return on Capital Employed (ROCE)	11.20%	14.60%	17.60%	16.50%	14.50%	42.60%
Earnings Yield	2.15%	4.20%	2.37%	1.91%	1.09%	-
FCF Yield	0.31%	0.04%	0.26%	0.00%	0.03%	-
Dividend Yield	0.28%	0.43%	0.24%	0.59%	0.22%	-
Payout Ratio	27.92%	21.51%	30.05%	17.24%	1.18%	1.48%
Buyback Yield / Dilution	-0.41%	-0.28%	-0.19%	-14.09%	-16.84%	0.19%
Total Shareholder Return	-0.11%	0.15%	0.05%	-13.50%	-16.62%	0.19%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.